Study of a new tablet in healthy adults
Part of Skin clinical trials.
This study tests a new investigational tablet in healthy adults to see how the body handles it and if it's safe. The results will help guide future research.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a healthy adult aged 18 years or older.
- Your body weight must be at least 50 kg (110 lbs) for men or 45 kg (99 lbs) for women, and your body mass index (BMI) must be between 18 and 30.
- You must be able to follow the study rules, including using contraception if you or your partner can become pregnant, and avoiding certain foods and activities before the study.
- You must not have certain medical conditions, such as immune system disorders, or be pregnant or breastfeeding.
- You must not have used certain medications, supplements, or drugs within the past few weeks, and you must not have participated in another clinical trial recently.
- You must not have a history of alcohol or drug abuse, or smoke or vape regularly.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication (HS-10374) taken by mouth to see if it is safe and effective for people with moderate to severe plaque psoriasis. It might help reduce the redness, scaling, and thickness of psoriasis plaques.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This study tests a new medication called HL40626S to see if it is safe in healthy adults. You would take the tablet and have regular checkups to monitor how your body responds.
This early-phase study tests an experimental oral tablet (UA026) in people with moderate to severe plaque psoriasis. The purpose is to see how safe and effective the drug is, and how it works in the body.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This study tests a new tablet in healthy adults to see how the body processes it and whether food changes its effects. It helps determine the right dose and safety for future patients.
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.